Hyperbaric prilocaine

Hyperbaric prilocaine is a specialized formulation of prilocaine used for spinal anesthesia, particularly in ambulatory (day-case) surgery settings. This formulation combines prilocaine with glucose to create a hyperbaric solution that provides more predictable spread within the cerebrospinal fluid. ## Pharmacology and Mechanism of Action Hyperbaric prilocaine is a local anesthetic that works by binding to the intracellular surface of sodium channels, blocking the influx of sodium into nerve cells[2]. This prevents action potential propagation and nerve function, effectively producing temporary anesthesia[2]. The hyperbaric nature of the solution (containing glucose) allows it to sink in cerebrospinal fluid when the patient is in a sitting position, providing more controlled distribution of the anesthetic effect. ## Clinical Applications Hyperbaric prilocaine 2% is primarily used for: - Spinal anesthesia in ambulatory (day-case) surgery settings[1][5][7] - Procedures of short to intermediate duration (up to 90 minutes)[3][6] - Lower extremity and lower abdominal procedures (40-60 mg dose)[3] - Perineal surgery (10-30 mg dose)[3][6] ## Advantages The key benefits of hyperbaric prilocaine include: - Faster onset and offset times compared to plain prilocaine solutions[6] - Shorter recovery time compared to bupivacaine (approximately 40 minutes earlier for first unassisted ambulation)[5] - Earlier patient discharge (approximately 29 minutes sooner than with bupivacaine)[5] - Lower incidence of transient neurological symptoms compared to lidocaine[1] - Complete recovery from motor block in approximately 90 minutes (with 40 mg dose)[6] - Readiness for discharge in approximately 4 hours from administration[3][6] ## Dosage The recommended dosage varies by procedure type: - 40-60 mg for lower extremities and lower abdominal procedures lasting up to 90 minutes[3][6] - 10-30 mg for perineal surgery[3][6] ## Safety Profile Hyperbaric prilocaine has shown a favorable safety profile with: - Similar incidence of hypotension compared to bupivacaine (17.4% vs 16.3%)[5] - No reported cases of transient neurological symptoms (TNS) or low back pain in some studies[5] - Lower risk of postoperative urinary retention compared to long-acting local anesthetics[7] The drug is particularly valuable in healthcare systems aiming to increase day-case surgery rates, as it can lead to service improvements through benefits to individual patients and overall service delivery[1].

Brand names

Ampres

Other names

hyperbaric prilocaineprilocaine 2% hyperbaricprilocaine hydrochloride hyperbaric